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All forms of atheroma are characterized by a risk of arterial wall rupture leading to clinical
complications. This involves medial and adventitial ruptures in abdominal aortic aneurysm
(AAA) and intimal cap rupture in vulnerable atherothrombotic plaques. Extracellular
proteases, including metalloproteinases, locally generated plasmin, and leukocyte elastase, are
important molecular mediators of atheroma progression via their matrix degradation
properties. The pathological evolution of AAA is linked to the biology of its associated mural
thrombus. Indeed, in aneurysmal segments lined by a thrombus, the wall is thinner, the
extracellular matrix more degraded, and the adventitial inflammatory response greater than in
segments that are not. Several lines of evidence highlight the role of the thrombus, in AAA,
as a reservoir of blood-borne proteases that conveys them from the lumen to the diseased wall.
In stenosing atheroma, both previous and recent studies provide evidence that recurrent
intraplaque hemorrhages play a dominant role in the evolution of the lesion toward
vulnerability. In this review, we draw a parallel between the role of protease conveyance and
activation of the mural thrombus in AAA and of intraplaque hemorrhages in stenosing
atheroma. We hypothesize that intraplaque hemorrhages convey blood-borne proteases into
lesions, where they are retained and activated upon thrombus/hematoma formation, thus
contributing significantly to their deleterious action. (J Am Coll Cardiol 2006;48:A3–9)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.098© 2006 by the American College of Cardiology Foundation
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ftherothrombotic plaques evolve toward partial or total wall
upture, causing arterial thrombosis in the case of stenosing
orms, and hemorrhage in the dilating aneurysmal forms.
ilatation and rupture of the arterial wall are linked to the
egradation of the extracellular matrix (ECM).
The proteases involved in atherosclerotic diseases and
heir complications belong mainly, but not exclusively, to
he matrix metalloproteinase (MMP) and serine-protease
amilies. Among serine-proteases, plasmin and leukocyte
lastase probably play a dominant role. A role for mast cell
hymase (1) and cyteine-proteases cannot be excluded.
atrix metalloproteinases constitute a family of numerous
inc-dependent metalloproteinases generally secreted as
ro-(inactive) forms that are activated extracellularly by
everal proteinases. They are produced by a variety of cell
ypes, including, for example, mesenchymal cells (smooth
uscle cells [SMCs] and fibroblasts), which constitutively
ecrete MMP-2 and -7 and macrophages and polymorpho-
uclear neutrophils in which inducible expression and/or
ecretion of MMP-9 occurs (2). Besides their action on
brillar ECM, MMPs participate in pathogenic processes,
y degrading other ECM constituents. Degradation of
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006, accepted April 18, 2006.CM not only modifies the cellular environment per se, but
lso generates degradation products that possess specific
iological activities (matrikins) and liberates ECM-bound
rowth factors. Matrix metalloproteinases also directly reg-
late proteases and antiprotease activities (3). For example,
MP-3 can activate proMMP-9 (4), and together they
leave plasminogen and inactivate plasminogen activator
nhibitor-1, 2-antiplasmin, and 1-antitrypsin (5–7).
The serine-protease plasmin is specifically activated via
onversion from plasminogen, a plasma-rich zymogen syn-
hesized by the liver, by serine-proteases, urokinase and
issue-type (t-PA) activators. Binding of plasminogen and
lasmin to fibrin, to other natural polymers, or to the cell
urface facilitates plasminogen activation enhances the pro-
eolytic activity, and prevents interactions with inhibitors
6), thus focusing the in situ action of plasmin within the
issue. In contrast, the soluble form of plasmin is immedi-
tely inactivated by binding to serpins. Besides proteases,
everal antiproteases can also bind to tissue. 2-antiplasmin
ovalently binds to fibrin (8,9), and protease nexin-1 (a
issue inhibitor of thrombin and plasmin) is strongly bound
o ECM (10).
Leukocyte elastase is mainly released by polymorphonu-
lear neutrophils (2) but has been recently shown to be also
xpressed and secreted by macrophages (11). The impor-
ance of neutrophils in thrombus evolution has long been
ecognized (12). Neutrophils are trapped at the site of fibrin
ormation, but more importantly, accumulate later and
nvade the thrombus, being 12 times more numerous in
c
a
p
(
b
a
i
c
p
o
w
S
(
i
d
t
a
a
p
b
(
p
A
A
o
S
r
t
r
c
l
a
n
u
t
a
h
o
n
(
n
c
c
o
a
s
A
c
c
a
c
a
o
t
p
K
a
s
E
T
c
a
S
b
p
fi
(
t
G
e
G
t
s
b
s
a
c
f
c
t
a
M
(
p
n
t
c
l
t
a
b
e
r
p
t
A4 Houard et al. JACC Vol. 48, No. 9 Suppl A
Blood-Borne Proteases in Atheroma November 7, 2006:A3–9lots than in circulating blood. Neutrophils have a high
ffinity for the fibrin-fibronectin network (13) and bind to
latelet-exposed P-selectin via the expression of PSGL-1
14). Neutrophil activation participates in fibrinolysis via
oth the release of urokinase and direct actions of elastase
nd cathepsin G (15,16). Plasmin and elastase are involved
n tissue remodeling through direct proteolysis of ECM
omponents and, importantly, via the activation of
roMMPs. An important consequence of protease activity
n the ECM is the suppression of cell matrix interactions,
hich triggers cell apoptosis in a process called anoïkis (17).
uch a phenomenon has been described for both plasmin
18) and elastase (19).
One of the main challenges concerning the understand-
ng of atherothrombotic complications is, therefore, to
etermine the hierarchy of the proteases involved, to localize
heir sources, and to elucidate the means of their retention
nd activation within tissues, thus defining new diagnostic
nd therapeutic targets. Our recent results suggest that
roteases conveyed by blood may be retained and activated
y mural thrombus formation in abdominal aortic aneurysm
AAA) as well as by intraplaque hemorrhages in vulnerable
laques.
CQUIRED AAA
bdominal aortic aneurysm formation involves degradation
f the medial layer (17), including both disappearance of
MCs by apoptosis (20) and absence of healing by cell
ecolonization, together with ECM degradation by pro-
eases, adventitial angiogenic and immunoinflammatory
esponses, and mural thrombus formation.
The dominant role of proteases—MMPs, serine- and
ysteine-proteases—in the evolution of AAAs toward en-
argement and rupture is well established. Abdominal aortic
neurysms are usually characterized by the presence of a
on-occlusive thrombus, through which blood flow contin-
es, permanently maintaining interfaces between blood and
hrombus at the luminal pole and thrombus and wall at the
bluminal pole. The most recently formed mural thrombus/
ematoma, at the luminal pole, is composed of patchy areas
f red blood cells and fibrin, retaining leukocytes (mainly
eutrophils), aggregated platelets, and plasma components
Fig. 1). The oldest, abluminal part is composed of a loose
etwork of degraded fibrin, in which the specific initial
omponents, including red blood cells and leukocytes,
Abbreviations and Acronyms
AAA  abdominal aortic aneurysm
ECM  extracellular matrix
HSP  heat shock protein
MMP  matrix metalloproteinase
MRI  magnetic resonance imaging
SMC  smooth muscle cell
t-PA  tissue-type activatorsannot be identified. Thus, the mural thrombus in AAA bffers a unique opportunity to study the different stages of
rterial thrombotic compositions and evolution within the
ame sample.
rguments for thrombus involvement in AAA. Several
linical observations have pointed to the involvement of the
oagulation and fibrinolytic cascades in the evolution of
neurysms (21,22). Earlier, the morphologic change (cres-
ent sign) of the mural thrombus (23) was correlated with
n impending risk of rupture (24,25). Furthermore, the risk
f rupture was shown to correlate with the size of the
hrombus (26,27). That biological activities of the thrombus
articipate in aneurysmal evolution was further supported by
azi et al. (28) who observed that the thrombus-associated
neurysmal wall was thinner and showed more frequent
igns of inflammation, SMC apoptosis, and degraded
CMs as compared with adjacent blood flow-lined wall.
heir findings suggested that thrombus formation may
ompromise the structural integrity and stability of the
rterial wall (29).
torage, activation, and release of blood-borne proteases
y the mural thrombus. The first clues to the presence of
roteolytic activities in the mural thrombus came from the
ndings of fibrin degradation products in AAA mural thrombi
30). Comparing mural thrombus to a retracted blood clot for
he presence of proteases, Gacko and Glowinski (31) and
acko et al. (32) showed an enrichment of cathepsins,
lastase, tissue factor, plasminogen, and t-PA in the former.
elatinase activities (MMP-2 and -9) are also higher in the
hrombus than in serum (33).
The mural thrombus of AAA is a complex laminated
tructure (30), containing several layers of thick, mixed,
rown fibrin clot, underlying a red thrombus on the luminal
urface (Fig. 1A). Neutrophils, platelets, and red blood cells
re present in the luminal layer (34) (Figs. 1B to 1D). In
ontrast, monocytes/macrophages are rare (Fig. 1E). The
ew that are present display signs of cell death such as cell
ontraction, suggesting apoptosis (Fig. 1E, inset). Localiza-
ion of neutrophils in the luminal part of the thrombus is
ssociated with the detection of increased levels of
MP-8, -9, and elastase, as compared with the other layers
Figs. 1F and 1G) (35). Matrix metalloproteinase-9 is, in
art, complexed to lipocalin, providing evidence for its
eutrophil origin.
In an initial report, we showed that spontaneous
hrombus formation and degradation in vitro was asso-
iated with the release of plasmin, responsible for clot
ysis, and proMMP-9 from neutrophils trapped within
he clot (36). In vivo, we next demonstrated that large
mounts of plasminogen accumulate in the mural throm-
us. In parallel, we showed that neutrophil-derived
lastase, at the luminal pole, prevents detersion and
ecolonization of the thrombus by SMCs or circulating
rogenitors (35).
These different observations suggest that the mural
hrombus, which permanently interfaces with circulating
lood, is biologically active. It undergoes continuous
r
c
m
fi
r
a
m
F
c
c
P
I
a
(
A
p
p
A5JACC Vol. 48, No. 9 Suppl A Houard et al.
November 7, 2006:A3–9 Blood-Borne Proteases in Atheromaenewal and fibrinolysis. In this concept, centrifugal
onveyance of plasminogen and activators from the lu-
en across the thrombus play an important role in
igure 1. Histologic aspect of the mural thrombus in abdominal aortic
orresponding to a newly formed clot, associating patchy areas of red blood
ellular components can no longer be recognized. The abluminal layer is c
resence of polymorphonuclear leucocytes in the luminal layer; these cells p
Ib/IIIa immunostaining showing the predominance of platelet aggregation
ntibody stains degranulating neutrophils that accumulate in the luminal la
E) Immunostaining with anti-CD68 antibody demonstrates the paucity
macrophage that appears contracted and apoptotic (100). (F) Matri
resent at the luminal pole of the thrombus (100). (G) Neutrophil el
olymorphonulear leukocytes (100).brinolysis (37) and MMP activation. Luminal thrombus tenewal is the main determinant of neutrophil trapping
nd plasminogen storage, causing protease release, plas-
in formation, and MMP activation, all of which con-
ysm. (A) Section through the thrombus showing the red luminal layer
nd fibrin. The intermediate layer represents a structured fibrin gel in which
sed of a loose network of degraded fibrin (hematoxylin/eosin, 10). (B)
inate in the fibrin-rich areas (hematoxylin/eosin, 60). (C) Glycoprotein
luminal pole of the thrombus in fibrin-rich areas (10). (D) Anti-CD66b
20). Inset shows neutrophils at different stages of degranulation (100).
nocyte/macrophages in the luminal layer of the thrombus (20). (Inset)
talloproteinase-9 immunostaining of gelatinase granules of neutrophils
immunostaining at the luminal pole of the thrombus colocalizes withaneur
cells a
ompo
redom
at the
yer (
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astaseribute to the expansive arterial wall remodeling, which
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Blood-Borne Proteases in Atheroma November 7, 2006:A3–9nexorably, sooner or later, leads to rupture. The throm-
us is also probably the main source of plasma markers of
AA evolution, such as for example MMP-9 (38,39),
hrombin-antithrombin, and plasmin-antiplasmin com-
lexes (22). These observations may have clinical conse-
uences in terms of diagnosis and therapeutics in AAA;
hrombus morphology, functional imaging, and plasma
iological markers could be of prognostic value.
ngiogenesis and inflammatory responses in the adven-
itia. In the arterial wall, mass transport of diffusible
ediators occurs unidirectionally by convection (40), due to
ransmural volume flow, from the lumen to the adventitia.
his outward convection of mediators, from the lumen
cross the wall, is probably the physiological determinant of
he adventitial response to arterial wall injury (41). The
dventitia responds to proteolytic injury by promoting
ngiogenesis, resulting in the external localization of inflam-
ation and lymphoid neogenesis (42). Fibroblast activation,
ediated by inflammation, probably limits AAA evolution
oward rupture through the stimulation of peripheral scle-
osis. The observation of periaortic inflammation, possibly
eading to the clinical entity of the “inflammatory AAA”
nd to retroperitoneal fibrosis (43), has focused investiga-
ions on adventitial inflammation in AAA (44,45). There-
ore, in AAA, mediators generated inwardly mainly by
roteolysis could be centrifugally convected toward the
dventitia, where they induce angiogenic, immunoinflam-
atory, and fibrotic responses.
igure 2. Histologic aspect of culprit lesions in carotid atheroma. (A) Macr
ore. (B) Magnetic resonance imaging of a carotid plaque hemorrhage. In
n T1 spin echocardiography, giving a hyperintensity signal. (C) Masson
eocapillaries within the lesion; and 2) intraplaque hemorrhage in the
athologies at different stages: fibrosis and hemorrhages. (D) Alizarin red staini
he core and at the interface between the core and the media.NTRAPLAQUE HEMORRHAGE AND
HROMBUS FORMATION IN PLAQUE VULNERABILITY
s compared with aneurysms, vulnerable stenosing plaques
Stary type V and VI lesions) are characterized by the retention
f biomaterials in the core of the lesion, encapsulated between
he luminal fibrous cap and the remaining media (46). The
ature of this biological gruel is heterogeneous and depends on
he stage of the lesion. The core includes components of
ifferent ages (unesterified lipid accumulation, frequent calci-
cations, macro- or microscopic hematoma) that can colocalize
ithin the same lesion. This highlights the discontinuous
volution of the plaque, from the initial lipid retention to the
ormation of a more complex core, leading to plaque instability
nd complications (Fig. 2).
istorical background. The proteolytic nature of the core in
theroma was first suggested by Galen (131 to 201 CE)
  atheroma  gruel). The involvement of re-
eated intraplaque hemorrhages in the evolution of atheroscle-
otic lesions toward complications was proposed as early as
938 (47), and the importance of thrombotic material in the
eneration of the pultaceous core has been emphasized in
ulmonary hypertension-induced plaque formation secondary
o thromboembolic events (48). The crucial role of repeated
ntraplaque hemorrhages in the evolution of stenosing ather-
ma toward complications has been recently revisited by
olodgie et al. (49). They linked unesterified cholesterol
ccumulation in the necrotic core of the lesion to specific red
ic aspect of a carotid culprit lesion showing the hemorrhagic nature of the
que hemorrhages are characterized by a focal post-contrast enhancement
chrome staining of a culprit carotid lesion, showing the presence of: 1)
This example highlights the heterogeneity of culprit lesions, involvingoscop
trapla
’s tri
core.ng of a culprit carotid lesion revealing the presence of calcification within
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November 7, 2006:A3–9 Blood-Borne Proteases in Atheromalood cell antigen expression (glycophorin). These histologic
bservations were corroborated by magnetic resonance imaging
MRI) of human carotid atheroma (50,51). Takaya et al. (52)
emonstrated that only plaques presenting hemorrhage within
he lesion, detected by MRI, showed progression over a period
f 18 months, including a decrease in lumen area and an
ncrease in core volume. Although the mechanisms leading to
ntraplaque hemorrhage are still not well established, numerous
tudies focus on the involvement of angiogenesis and the
nfiltration of microvessels from the adventitial vasa vasorum to
nvade the shoulder region of the plaque (53).
rom intraplaque hemorrhage to plaque vulnerability. In-
raplaque hemorrhages convey into the lesion all the blood
omponents, including red blood cells, leukocytes (of which
0% are neutrophils), platelets, and plasma proteins. Plasma
embranes of circulating cells, including red blood cells
49), activated platelets (54,55), and probably dead leuko-
ytes, participate in unesterified cholesterol retention within
he core (Fig. 3). Platelet aggregation, prothrombin activa-
ion, and fibrinogen proteolysis all induce fibrin polymer-
zation, which is potentially capable of trapping neutrophilsigure 3. Representative diagram of the biological components conveyed by the
e  iron; MPO  myeloperoxidase; PMN  polymorphonuclear leukocyte; Rnd other leukocytes, and of binding plasmin and elastase
Fig. 3). In order to further explore the deleterious potential
f the core contents, the release of activated proteases by
arotid plaque endarterectomy specimens at different
tages of evolution (type III to VI lesions of the Stary
lassification) were analyzed and compared with normal
ndarteries (mammary arteries). The greater the size and
he complexity of the core, the greater was the release of
ctivated proteases, including plasmin and the activated
elatinases MMP-2 and -9 (56). In parallel, proteolytic
egradation of secreted heat shock protein (HSP) 27
ccurs in diseased tissues (57). Heat shock protein 27 was
reviously identified using a differential proteomics ap-
roach as a very sensitive biomarker, which is decreased
n plasma from atherosclerotic patients (58). Microdis-
ection of the lesion to separate cap, core, and media
emonstrated that, among these different lesion compart-
ents, the core is the major site of plasminogen/plasmin
nd gelatinase storage and activation (56). Plasmin ac-
ounts for a major part of the proteolytic degradation of
SP27 (57).intraplaque hemorrhage to the core and their roles in plaque progression.
BC  red blood cell.
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Blood-Borne Proteases in Atheroma November 7, 2006:A3–9Other enzymatic activities associated with the core of the
theromatous lesion have also been described, including
hospholipase A2 (59) and sphingomyelinase (60), which
re able to modify low-density lipoprotein particles and
enerate unesterified cholesterol from cell membranes. This
nzymatic modification of low-density lipoprotein is a key
o understanding how cholesterol retention within the
rterial wall could be the driving force for the inflammatory
esponse in atheroma (61,62). This concept of the response
o lipoprotein retention could be extrapolated to apply also
o the phenomenon of core retention of proteolytic activi-
ies, which may also play a crucial role in the different
echanisms of plaque progression.
The core of the lesion is a cytotoxic environment,
ssentially acellular, containing cell debris and only a few
ctive macrophages (preferentially located in the cap). De-
ersion of cell debris by macrophages is a prerequisite for a
ormal healing process. This main function of macrophages
s prevented in atherosclerosis, probably because they un-
ergo apoptosis, a hallmark of human atherosclerotic lesions
63,64). Macrophage survival is dependent on adhesion
65), and proteases trigger cell apoptosis via ECM proteol-
sis (18,19). Proteases could thus represent central media-
ors of the cytotoxicity of the core. Such a function of
roteases was previously proposed in AAA to explain the
bsence of detersion and recolonization of the mural throm-
us by mesenchymatous cells (35).
The lesional core in vulnerable atheroma is, therefore, the main
ite of retention and activation for proteases conveyed by repeated
ntraplaque hemorrhages. These blood-borne proteases likely rep-
esent a major determinant for cap rupture on the luminal side,
eading to occlusive thrombus, as well as for outward expansive
emodeling (66). The proteolytic nature of the lesional core
ould thus explain the link observed between the expansive
emodeling and plaque hemorrhages (67) or vulnerability (68).
herefore, the eccentric growth of the plaque and its possible
upture into the lumen, both suggest a central proteolytic role
f the core in atheroma progression (69).
onclusions. Abdominal aortic aneurysm and atheroma-
ous plaques are 2 clinically and etiopathogenic different
orms of atherosclerosis that are characterized by the for-
ation of a mural thrombus in the former and the recur-
ence of intraplaque hemorrhages in the latter. Both play a
rucial role in the progression of the disease. Mural throm-
us is the site of blood-borne storage and activation of
roteases necessary for the proteolytic aggression of the wall.
ntraplaque hemorrhages convey blood-borne proteases into
he lesional core. In this review, we argue for a similar role
f conveyance, storage, and activation of proteases between
ural thrombus in AAA and recurrent intraplaque hemor-
hages and thrombus/hematoma formation in atheromatous
laques. The concept of “proteolytic retention” within the
iseased arterial wall offers new diagnostic and therapeutic
argets in atheroma.cknowledgments
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